PharmaRentosertib Shows Potential to Lower Biological Age in Small AI Drug Study
An AI-developed lung disease drug lowered biological age markers across six aging clocks, but researchers cautioned that the findings remain preliminary.
Pharma · Company
Insilico Medicine
Covered since Most recent
Insilico Medicine's AI-developed drug, Rentosertib, demonstrated potential in a small study by lowering biological age markers across six aging clocks. However, researchers noted that these findings are preliminary and require further investigation.
0Stories
+0 in the last 30 days
0Deployments tracked
Latest: Sep 7, 2001
42patients in study
Latest tracker entry
Deployments
In the tracker →- rentosertib
pilot42 treat idiopathic pulmonary fibrosis
Stories
1 storyPharma
